Drug Industry Continues to Fight It; President Biden Proposes to Expand ItThe Inflation Reduction Act of 2022 (IRA), signed into law by President Biden on August 16, 2022, has already provided cost-savings for Medicare beneficiaries through … [Read more...] about Implementation of Medicare Drug Law Proceeds
Medicare Part D / Prescription Drugs
Center for Medicare Advocacy Submits Comment on Proposed 2025 Medicare Advantage and Part D Rule
On January 5, 2024, the Center submitted comments to a proposed rule for Medicare Advantage (MA) and Part D issued by the Centers for Medicare & Medicaid Services (CMS) titled: Medicare Program; Contract Year 2025 Policy and Technical Changes to … [Read more...] about Center for Medicare Advocacy Submits Comment on Proposed 2025 Medicare Advantage and Part D Rule
New Medicare Drug Provisions Now in Effect – Including Out-of-Pocket Changes
The Inflation Reduction Act of 2022 (IRA), signed into law by President Biden on August 16, 2022, has already provided cost-savings for Medicare beneficiaries through provisions that took effect last year in 2023, including a monthly cap of $35 for … [Read more...] about New Medicare Drug Provisions Now in Effect – Including Out-of-Pocket Changes
Center Joins Fight Against Drug Manufacturer Seeking to End Medicare Price Negotiations
This week, the Center for Medicare Advocacy joined a coalition of advocates led by AARP that is urging a federal court to reject an attempt to block Medicare’s drug price negotiation program. The case is one of many brought by drug manufacturers … [Read more...] about Center Joins Fight Against Drug Manufacturer Seeking to End Medicare Price Negotiations
More Medicare Prescription Drug Help for Beneficiaries in 2024 – Including Out-of-Pocket Cap
The Inflation Reduction Act of 2022 (IRA), signed into law by President Biden on August 16, 2023, is already providing cost-savings for Medicare beneficiaries in 2023, including a monthly cap of $35 for covered insulin and free vaccines for certain … [Read more...] about More Medicare Prescription Drug Help for Beneficiaries in 2024 – Including Out-of-Pocket Cap
Medicare Drug Price Negotiation Program Begins After Encouraging Court Decision
A federal court has rejected a bid by the pharmaceutical industry and its allies to stop the newly established Medicare drug price negotiation program before it starts. On September 29, 2023, Judge Michael J. Newman of the U.S. District Court for … [Read more...] about Medicare Drug Price Negotiation Program Begins After Encouraging Court Decision
CMS Releases Notices Regarding LIS
The Centers for Medicare & Medicaid Services (CMS) notified Medicare Advantage organizations and Part D Plans that it will conduct reassignment this month of beneficiaries eligible for the Part D Low-Income Subsidy (LIS) who are enrolled in … [Read more...] about CMS Releases Notices Regarding LIS
One-Year Anniversary of Medicare Prescription Drug Law: Beneficiaries Already Saving Money but Drug Industry Fights Progress
August 16, 2023 marked the one-year anniversary of the Inflation Reduction Act of 2022 (IRA) being signed into law by President Biden. As outlined in a previous CMA Alert (March 2, 2023), the IRA law includes historic prescription drug provisions … [Read more...] about One-Year Anniversary of Medicare Prescription Drug Law: Beneficiaries Already Saving Money but Drug Industry Fights Progress
CMS Request for Information Regarding Self-Administered Drugs – Center for Medicare Advocacy Calls for Reform
The Social Security Act permits Medicare Part B to pay for drugs and biologicals that are not usually self-administered by the patient and furnished as “incident to” a physician's service. As a result, drugs that are “usually self-administered” are … [Read more...] about CMS Request for Information Regarding Self-Administered Drugs – Center for Medicare Advocacy Calls for Reform
Inflation Reduction Act (Medicare Drug Law) Updates – Including Part D Low Income Subsidy
HHS Actions to Increase LIS EnrollmentAmong other changes aimed at reducing drug costs for both Medicare beneficiaries and the Medicare program at large, a provision of the Inflation Reduction Act of 2022 (IRA) expands access to the Part D Low … [Read more...] about Inflation Reduction Act (Medicare Drug Law) Updates – Including Part D Low Income Subsidy